781979567	781979567	CD	B-NP	O
|	|	NN	I-NP	O
MCH	MCH	NN	I-NP	O
|	|	NN	I-NP	O
91301170	91301170	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8750646	8750646	CD	B-NP	O
|	|	CC	I-NP	O
7/12/2005	7/12/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CHF	CHF	NN	I-NP	I-protein
exacerbation	exacerbation	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/9/2005	3/9/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/6/2005	3/6/2005	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
GOUD	GOUD	NNP	B-NP	O
,	,	,	O	O
JODY	JODY	NNP	B-NP	O
499-78-41-6	499-78-41-6	CD	I-NP	O
Hunt	Hunt	NNP	I-NP	O
A	A	NNP	I-NP	O
Land	Land	NNP	I-NP	O
Cinwinwoodaolk	Cinwinwoodaolk	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
11/18/05	11/18/05	CD	B-NP	O
AT	AT	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
STOCKE	STOCKE	NN	B-NP	O
,	,	,	O	O
SHERMAN	SHERMAN	NNP	B-NP	O
K.	K.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ASA	ASA	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	I-NP	O
ACID	ACID	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
81	81	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
120	120	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
ZESTRIL	ZESTRIL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
30	30	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
and	and	CC	O	O
please	please	VB	B-VP	O
notify	notify	VBP	O	O
h.o.	h.o.	NNP	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
8/17/05	8/17/05	CD	B-NP	O
by	by	IN	B-PP	O
STEIDEL	STEIDEL	NN	B-NP	O
,	,	,	O	O
TROY	TROY	NNP	B-NP	O
WADE	WADE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ALDACTONE	ALDACTONE	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
10927159	10927159	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
SPIRONOLACTONE	SPIRONOLACTONE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/17/05	8/17/05	CD	B-NP	O
by	by	IN	B-PP	O
WEINZETL	WEINZETL	NNP	B-NP	O
,	,	,	O	O
JOEY	JOEY	NNP	B-NP	O
CARROLL	CARROLL	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
ALDACTONE	ALDACTONE	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
SPIRONOLACTONE	SPIRONOLACTONE	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
25	25	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Give	Give	NN	I-NP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/17/05	8/17/05	CD	B-NP	O
by	by	IN	B-PP	O
SABHA	SABHA	NNP	B-NP	O
,	,	,	O	O
SPENCER	SPENCER	NNP	B-NP	O
ELROY	ELROY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
SPIRONOLACTONE	SPIRONOLACTONE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
SPIRONOLACTONE	SPIRONOLACTONE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
ZOCOR	ZOCOR	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
SIMVASTATIN	SIMVASTATIN	NN	I-NP	I-protein
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	O
instructs	instruct	NNS	I-NP	O
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

TOPROL	TOPROL	NN	B-NP	O
XL	XL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
METOPROLOL	METOPROLOL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
SUST	SUST	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O

75	75	CD	B-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
,	,	,	O	O
hr	hr	NN	B-NP	O
<	<	SYM	O	O
55	55	CD	B-NP	O
and	and	CC	O	O
call	call	VB	B-VP	O
h.o	h.o	NN	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Fluid	Fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr	Dr	NNP	B-NP	O
Canes	Canes	NNP	I-NP	O
,	,	,	O	O
GB	GB	NN	B-NP	B-protein
1-2	1-2	NN	I-NP	I-protein
wks	wk	NNS	I-NP	I-protein
,	,	,	O	O
MRH	MRH	NNP	B-NP	O
Clinic	Clinic	NNP	I-NP	O
1-2	1-2	NN	I-NP	O
wks	wk	NNS	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CHF	CHF	NNP	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
HTN	HTN	NN	I-NP	O
,	,	,	O	O
borderline	borderline	JJ	B-NP	O
DM2	DM2	NN	I-NP	O
,	,	,	O	O
obesity	obesity	NN	B-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
LHC	LHC	NN	B-NP	B-DNA
1/27	1/27	CD	I-NP	I-DNA
-	-	HYPH	O	O
>	>	SYM	B-NP	O
no	no	DT	B-NP	O
epicardial	epicardial	JJ	I-NP	B-protein
disease	disease	NN	I-NP	I-protein
RHC	RHC	NN	I-NP	I-protein
1/27	1/27	CD	I-NP	I-protein
-	-	HYPH	B-NP	O
>	>	SYM	I-NP	O
mildly	mildly	RB	I-NP	O
elevated	elevated	JJ	I-NP	O
filling	filling	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
OTHER	OTHER	NNP	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
DOE	DOE	NNP	B-NP	O
x	x	CC	O	O
6	6	CD	B-NP	O
months	month	NNS	I-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
67	67	CD	B-NP	O
M	M	NN	I-NP	O
with	with	IN	B-PP	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
,	,	,	O	O
DM2	DM2	NN	B-NP	B-protein
,	,	,	O	O
?	?	.	O	O

NSTEMI	NSTEMI	NN	B-NP	O
in	in	IN	B-PP	O
1999	1999	CD	B-NP	O
-LRB-	-LRB-	SYM	O	O
cath	cath	NN	B-NP	B-protein
4/8	4/8	CD	I-NP	I-protein
with	with	IN	B-PP	O
non-occlusive	non-occlusive	JJ	B-NP	O
CAD	CAD	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
presenting	present	VBG	B-VP	O
with	with	IN	B-PP	O
6	6	CD	B-NP	O
months	month	NNS	I-NP	O
of	of	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
DOE	DOE	NN	B-NP	O
and	and	CC	I-NP	O
PND	PND	NN	I-NP	B-protein
,	,	,	O	O
increased	increase	VBN	B-NP	O
abdomnal	abdomnal	JJ	I-NP	O
girth	girth	NN	I-NP	O
,	,	,	O	O
8lb	8lb	NN	B-NP	O
wt	wt	NN	I-NP	O
gain	gain	NN	I-NP	O
in	in	IN	B-PP	O
last	last	JJ	B-NP	B-protein
2	2	CD	I-NP	I-protein
wks	wk	NNS	I-NP	I-protein
and	and	CC	O	O
increased	increase	VBN	B-NP	O
LEE	LEE	NN	I-NP	B-protein
in	in	IN	B-PP	O
last	last	JJ	B-NP	O
1	1	CD	I-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

2-3	2-3	CD	B-NP	O
pillow	pillow	NN	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
.	.	.	O	O

Ran	Ran	NN	B-NP	B-protein
out	out	IN	B-PP	O
of	of	IN	B-PP	O
BP	BP	NN	B-NP	O
meds	med	NNS	I-NP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

Lives	Life	NNS	B-NP	O
in	in	IN	B-PP	O
Sa	Sa	NNP	B-NP	O
Rieert	Rieert	NNP	I-NP	O
Tulak	Tulak	NNP	I-NP	O
,	,	,	O	O
comes	come	VBZ	B-VP	O
to	to	TO	B-PP	O
Son	Son	NNP	B-NP	O
Tallsiron	Tallsiron	NNP	I-NP	O
Ker	Ker	NNP	I-NP	O
intermittently	intermittently	RB	B-ADVP	O
for	for	IN	B-PP	O
medical	medical	JJ	B-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	VBN	B-NP	B-cell_line
165/115	165/115	CD	I-NP	I-cell_line
-	-	HYPH	O	O
>	>	SYM	O	O
130s/100	130s/100	CD	B-NP	O
after	after	IN	B-PP	O
lasix	lasix	CD	B-NP	O
40	40	CD	I-NP	O
,	,	,	I-NP	O
80	80	CD	I-NP	O
iv	iv	NN	I-NP	O
and	and	CC	I-NP	O
lopressor	lopressor	NN	I-NP	O
,	,	,	O	O
started	start	VBD	B-VP	O
heparin	heparin	NN	B-NP	O
gtt	gtt	NN	I-NP	O
.	.	.	O	O

PMH	PMH	NN	B-NP	O
:	:	:	O	O
HTN	HTN	NN	B-NP	B-protein
/	/	SYM	B-NP	O
DM2	DM2	NN	I-NP	B-protein
-LRB-	-LRB-	SYM	B-VP	O
not	not	RB	O	O
on	on	IN	B-PP	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
any	any	DT	B-NP	O
kind	kind	NN	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
/	/	SYM	B-VP	O
obesity	obesity	NN	B-NP	O
Meds	Med	NNS	I-NP	O
:	:	:	O	O
not	not	RB	O	O
taking	take	VBG	B-VP	O
any	any	DT	B-NP	O
-LRB-	-LRB-	NN	I-NP	B-protein
prescribed	prescribe	VBD	B-VP	O
atenolol	atenolol	NN	B-NP	O
100	100	CD	I-NP	O
bid	bid	NN	B-VP	O
,	,	,	O	O
norvasc	norvasc	NN	B-NP	O
10	10	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
NKDA	NKDA	NN	I-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
96.7	96.7	CD	B-NP	O
67128/80	67128/80	CD	I-NP	O
22	22	CD	I-NP	O
98	98	CD	I-NP	O
%	%	NN	I-NP	O
2L	2L	NN	I-NP	O
tachypneic	tachypneic	JJ	B-ADJP	O
,	,	,	O	O
sitting	sit	VBG	B-VP	O
up	up	RP	B-PRT	O
JVP	JVP	NN	B-NP	O
11-12	11-12	CD	I-NP	O
RRR	RRR	NN	I-NP	O
distant	distant	JJ	I-NP	O
heart	heart	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
m/r/g	m/r/g	NN	I-NP	B-protein
bibasilar	bibasilar	JJ	I-NP	I-protein
crackles	crackle	NNS	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
lower	low	JJR	B-NP	O
1/2	1/2	CD	I-NP	O
in	in	IN	B-PP	O
ED	ED	JJ	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
extr	extr	NN	I-NP	O
1	1	CD	I-NP	O
+	+	SYM	B-NP	O
pitting	pit	VBG	B-VP	O
edema	edema	NN	B-NP	O
to	to	TO	B-PP	O
mid	mid	JJ	B-NP	O
shin	shin	NN	I-NP	O
,	,	,	O	O
cool	cool	VBP	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
dp	dp	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
LABS	LABS	NNP	B-NP	O
:	:	:	O	O
HCO3	HCO3	NN	B-NP	O
18	18	CD	I-NP	O
/	/	SYM	B-VP	O
HCT	HCT	NN	B-NP	B-protein
49.6	49.6	CD	I-NP	I-protein
/	/	SYM	B-VP	O
BNP	BNP	NN	B-NP	O
1161	1161	CD	I-NP	O
TnI	TnI	NN	I-NP	O
0.43	0.43	CD	B-NP	O
/	/	SYM	I-NP	O
CK	CK	NN	I-NP	B-protein
196	196	CD	I-NP	I-protein
/	/	SYM	B-VP	O
MB	MB	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
CXR	CXR	NN	I-NP	I-protein
:	:	:	O	O
enlarged	enlarge	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
silhouette	silhouette	NN	I-NP	O
and	and	CC	I-NP	O
pulm	pulm	NN	I-NP	O
edema	edema	NN	I-NP	O
EKG	EKG	NN	I-NP	O
:	:	:	O	O
LBBB	LBBB	NN	B-NP	B-protein
-LRB-	-LRB-	:	O	O
new	new	JJ	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
HOSPITAL	HOSPITAL	NNP	I-NP	O
COURSE	COURSE	NNP	I-NP	O
OVERVIEW	OVERVIEW	NNP	I-NP	O
:	:	:	O	O
67M	67M	NN	B-NP	O
with	with	IN	B-PP	O
non	non	JJ	B-NP	O
occlusive	occlusive	JJ	I-NP	O
CAD	CAD	NN	I-NP	O
on	on	IN	B-PP	O
cath	cath	NN	B-NP	B-protein
4/8	4/8	CD	I-NP	I-protein
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
s/s	s/	NNS	B-NP	O
L	L	NN	I-NP	O
and	and	CC	I-NP	O
R	R	NN	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
and	and	CC	O	O
troponin	troponin	NN	B-NP	O
leak	leak	NN	I-NP	O
attrubuted	attrubute	VBD	B-VP	O
to	to	TO	B-PP	O
CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

ECHO	ECHO	NN	B-NP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
showed	show	VBD	B-VP	O
EF	EF	NN	B-NP	O
15-20	15-20	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Diuresed	Diurese	VBN	B-NP	O
3	3	CD	I-NP	O
kg	kg	NN	I-NP	O
,	,	,	O	O
started	start	VBN	B-VP	O
on	on	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
medical	medical	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
ISCH	ISCH	NN	B-NP	O
:	:	:	O	O
Ruled	Rule	VBN	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
,	,	,	O	O
troponin	troponin	NN	B-NP	O
leak	leak	NN	I-NP	O
attributed	attribute	VBN	B-VP	O
to	to	TO	B-PP	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
however	however	RB	B-VP	O
given	give	VBN	I-VP	O
low	low	JJ	B-NP	O
EF	EF	NN	I-NP	O
<	<	SYM	B-NP	O
15	15	CD	B-NP	O
%	%	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
in	in	IN	B-PP	O
1999	1999	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	O	O
new	new	JJ	B-NP	O
LBBB	LBBB	NNP	I-NP	O
went	go	VBD	B-VP	O
for	for	IN	B-PP	O
LHC	LHC	NN	B-NP	B-protein
1/27	1/27	CD	I-NP	I-protein
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
for	for	IN	B-PP	O
ischemic	ischemic	JJ	B-NP	O
CMP	CMP	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
epicardial	epicardial	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

PUMP	PUMP	NN	B-NP	O
:	:	:	O	O
fluid	fluid	NN	B-NP	O
OL	OL	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Felt	Felt	RB	B-ADVP	O
much	much	RB	B-ADJP	O
better	good	JJR	I-ADJP	O
after	after	IN	B-PP	O
3	3	CD	B-NP	O
kg	kg	NN	I-NP	O
diuresis	diuresis	NN	I-NP	O
,	,	,	O	O
RHC	RHC	NN	B-NP	B-protein
on	on	IN	B-PP	O
1/27	1/27	NN	B-NP	O
showed	show	VBD	B-VP	O
mildly	mildly	RB	B-NP	O
elevated	elevated	JJ	I-NP	O
filling	filling	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
.	.	.	O	O

DRY	DRY	NN	B-NP	O
WEIGHT	WEIGHT	NN	I-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
WAS	WAS	NNS	I-NP	O
:	:	:	O	O
SBPs	SBP	NNS	B-NP	B-protein
on	on	IN	B-PP	O
current	current	JJ	B-NP	O
regimen	regimen	NN	I-NP	O
were	be	VBD	B-VP	O
110-120	110-120	CD	B-NP	O
.	.	.	O	O

Started	Start	VBN	B-VP	O
on	on	IN	B-PP	O
ACE	ACE	NN	B-NP	O
,	,	,	O	O
BB	BB	NN	B-NP	B-protein
,	,	,	O	O
aldactone	aldactone	NN	B-NP	O
and	and	CC	O	O
transitioned	transitione	VBN	B-VP	O
to	to	TO	I-VP	O
po	po	VB	I-VP	O
lasix	lasix	NN	B-NP	O
.	.	.	O	O

RR	RR	NN	B-NP	O
:	:	:	O	O
admission	admission	NN	B-NP	O
EKG	EKG	NN	I-NP	O
showed	show	VBD	B-VP	O
LBBB	LBBB	NN	B-NP	B-protein
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
new	new	JJ	B-ADJP	O
.	.	.	O	O

Remained	Remain	VBN	B-VP	O
stable	stable	JJ	B-ADJP	O
in	in	IN	B-PP	O
NSR	NSR	NN	B-NP	B-protein
with	with	IN	B-PP	O
LBBB	LBBB	NN	B-NP	B-protein
.	.	.	O	O

Had	Have	VBD	B-VP	O
4-6	4-6	CD	B-NP	O
beat	beat	JJ	I-NP	O
runs	run	NNS	I-NP	O
of	of	IN	B-PP	O
WCT	WCT	NN	B-NP	O
on	on	IN	B-PP	O
tele	tele	NN	B-NP	O
.	.	.	O	O

HEME	HEME	NN	B-NP	B-protein
:	:	:	O	O
HCT	HCT	NN	B-NP	O
stable	stable	JJ	I-NP	O
post	post	NN	I-NP	O
cath	cath	NN	I-NP	O
ENDO	ENDO	NN	I-NP	O
:	:	:	O	O
per	per	IN	B-PP	O
pt	pt	NN	B-NP	O
had	have	VBD	B-VP	O
diagnosis	diagnosis	NN	B-NP	O
of	of	IN	B-PP	O
DM2	DM2	NN	B-NP	O
x2	x2	NN	I-NP	O
years	year	NNS	I-NP	O
,	,	,	B-NP	O
not	not	RB	I-NP	O
clear	clear	JJ	B-ADJP	O
if	if	IN	B-SBAR	O
on	on	IN	B-PP	O
treatment	treatment	NN	B-NP	O
,	,	,	O	O
though	though	IN	B-SBAR	O
patient	patient	NN	B-NP	O
thinks	think	VBZ	B-VP	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
something	something	NN	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

FSG	FSG	NN	B-NP	O
here	here	RB	B-ADVP	O
on	on	IN	B-PP	O
ADA	ADA	NN	B-NP	O
diet	diet	NN	I-NP	O
were	be	VBD	B-VP	O
100-120	100-120	CD	B-NP	O
in	in	IN	B-PP	O
AM	AM	NN	B-NP	O
and	and	CC	O	O
pre-lunch	pre-lunch	JJ	B-NP	O
,	,	,	I-NP	O
pre-dinner	pre-dinner	JJ	I-NP	O
170-190	170-190	CD	I-NP	O
.	.	.	O	O

Suggested	Suggest	VBN	B-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
exercise	exercise	NN	B-NP	O
and	and	CC	O	O
metformin	metformin	NN	B-NP	O
500	500	CD	I-NP	O
qd	qd	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
will	will	MD	B-VP	O
see	see	VB	I-VP	O
his	his	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
who	who	WP	B-NP	O
will	will	MD	B-VP	O
likely	likely	RB	I-VP	O
address	address	VB	I-VP	O
this	this	DT	B-NP	O
issue	issue	NN	I-NP	O
as	as	IN	B-SBAR	O
his	his	PRP$	B-NP	O
fingersticks	fingerstick	NNS	I-NP	O
have	have	VBP	B-VP	O
him	him	PRP	B-NP	O
elevated	elevate	VBN	B-VP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

RENAL	RENAL	NN	B-NP	O
:	:	:	O	O
mild	mild	JJ	B-NP	O
CRI	CRI	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
1.3	1.3	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
FC	FC	NN	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Weigh	Weigh	VB	B-VP	O
yourself	yourself	PRP	B-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
your	your	PRP$	B-NP	O
weight	weight	NN	I-NP	O
goes	go	VBZ	B-VP	O
up	up	RP	B-PRT	O
by	by	IN	B-PP	O
2	2	CD	B-NP	O
lbs	lb	NNS	I-NP	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
about	about	IN	B-PP	O
adjusting	adjust	VBG	B-VP	O
your	your	PRP$	B-NP	O
lasix	lasix	NN	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	O
need	need	VBP	B-VP	O
to	to	TO	I-VP	O
stick	stick	VB	I-VP	O
to	to	TO	B-PP	O
your	your	PRP$	B-NP	O
low	low	JJ	I-NP	O
salt	salt	NN	I-NP	O
and	and	CC	O	O
2	2	CD	B-NP	O
liter	liter	NN	I-NP	O
fluid	fluid	NN	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
RUCINSKI	RUCINSKI	NN	B-NP	O
,	,	,	O	O
LAUREN	LAUREN	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
HQ703	HQ703	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
11/18/05	11/18/05	CD	I-NP	O
@	@	SYM	B-NP	O
01	01	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

